ArticleThe Journal of clinical investigation2022

KRAS mutations as essential promoters of lymphangiogenesis via extracellular vesicles in pancreatic cancer.

Radu Pirlog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.